$NASDAQ:CCCC

C4 Therapeutics Intrinsic Value – C4 Therapeutics Upgraded to Hold by Merck News, But Not Ready for Buy Yet
Gallery

C4 Therapeutics Intrinsic Value – C4 Therapeutics Upgraded to Hold by Merck News, But Not Ready for Buy Yet

🌧️Trending News C4 Therapeutics ($NASDAQ:CCCC) has recently been upgraded from a "sell" rating to a "hold" rating by Merck News. [...]

By GoodWhale|December 21, 2023|Categories: Biotechnology, Intrinsic Value|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

C4 THERAPEUTICS Reports Earnings Results for Q2 of FY2023
Gallery

C4 THERAPEUTICS Reports Earnings Results for Q2 of FY2023

🌥️Earnings Overview C4 THERAPEUTICS ($NASDAQ:CCCC) reported its earnings results for the second quarter of FY2023, which ended on June 30 [...]

By GoodWhale|August 26, 2023|Categories: Biotechnology, Earnings Report|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

C4 Therapeutics Intrinsic Stock Value – Analysts at HC Wainwright Reduce Price Target of C4 Therapeutics to $25.00
Gallery

C4 Therapeutics Intrinsic Stock Value – Analysts at HC Wainwright Reduce Price Target of C4 Therapeutics to $25.00

Trending News 🌥️ Analysts at HC Wainwright have recently reduced their price target for C4 Therapeutics ($NASDAQ:CCCC) to $25.00, according [...]

By GoodWhale|May 13, 2023|Categories: Biotechnology, Intrinsic Value, Market Price|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

C4 Therapeutics Earnings Beat Expectations Despite Revenue Miss
Gallery

C4 Therapeutics Earnings Beat Expectations Despite Revenue Miss

Trending News ☀️ C4 Therapeutics ($NASDAQ:CCCC) recently reported its earnings for the quarter, beating expectations despite a revenue miss. The [...]

By GoodWhale|May 5, 2023|Categories: Biotechnology|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

C4 Therapeutics Sees Steady Trading Volume Despite 5.53% Drop in 2023.
Gallery

C4 Therapeutics Sees Steady Trading Volume Despite 5.53% Drop in 2023.

Trending News ☀️ C4 Therapeutics ($NASDAQ:CCCC) Inc. has seen a steady average trading volume in recent days, despite a slight [...]

By GoodWhale|March 23, 2023|Categories: Biotechnology|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

Analysts Lower Earnings Estimates for C4 Therapeutics, (NASDAQ).
Gallery

Analysts Lower Earnings Estimates for C4 Therapeutics, (NASDAQ).

Trending News 🌧️ Recent news of analysts at Brookline Capital Management revising their earnings estimates for C4 Therapeutics ($NASDAQ:CCCC), Inc. [...]

By GoodWhale|March 6, 2023|Categories: Biotechnology, Earnings Report|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

C4 Therapeutics Predicted to See Strong Earnings Growth in FY2027
Gallery

C4 Therapeutics Predicted to See Strong Earnings Growth in FY2027

Trending News ☀️ C4 Therapeutics Stock Intrinsic Value – C4 Therapeutics ($NASDAQ:CCCC) is an innovative biopharmaceutical company focused on developing [...]

By GoodWhale|January 17, 2023|Categories: Biotechnology|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

Shareholders of C4 Therapeutics Suffer Major Losses After 21% Stock Drop
Gallery

Shareholders of C4 Therapeutics Suffer Major Losses After 21% Stock Drop

Trending News 🌧️ C4 Therapeutics Intrinsic Value – C4 Therapeutics ($NASDAQ:CCCC) is a biopharmaceutical company focused on developing medicines that [...]

By GoodWhale|December 23, 2022|Categories: Intrinsic Value|Tags: $NASDAQ:CCCC, Biotechnology, NASDAQ|0 Comments

C4 Therapeutics Ranked Top Healthcare Stock by InvestorObserve

Trending News ☀️ C4 Therapeutics ($NASDAQ:CCCC) is a clinical-stage biopharmaceutical company that focuses on the development of small-molecule therapies for [...]